Thank you, Tarang. Our second quarter results were outstanding. Q2 net sales grew 33% year-over-year, driven by broad-based strength across national and international retailers as well as digital commerce. Our consumption trends continue to be well balanced, between increases in both AUR and units and between strength in both our core products as well as recent innovation. Our digitally led strategy continues to serve us well. In Q2, digital consumption trends were up over 75% year-over-year. Digital channels drove 15% of our total consumption in Q2, as compared to 12% a year ago. Gross margin of 65% and was up approximately 190 basis points compared to prior year. We saw gross margin benefits from price increases, cost savings and margin accretive mix. These gross margin benefits more than offset the impact of inventory adjustments and higher transportation costs in the quarter. On an adjusted basis, as a percentage of sales was 46%, compared to 49% last year. We drove leverage in our non-marketing SG&A expenses as a result of our better-than-expected top line trends. Marketing and digital investment for the quarter was approximately 16% of net sales, in line versus a year ago and was lower than expected on a percentage basis given our significant top line outperformance. As Tarang mentioned, with the combination of our top line momentum and strong ROI, we now expect marketing and digital investment for the full year to be approximately 19% of net sales. At the high end of our 17% to 19% range. Q2 adjusted EBITDA was $27 million, up 47% versus last year. And adjusted EBITDA margin was approximately 22% of net sales. Adjusted net income was $20 million or $0.36 per diluted share compared to $11 million or $0.21 per diluted share, a year ago. Moving to the balance sheet and cash flow, our balance sheet remains strong, and we believe this, positions us well to execute our long-term growth plans. We ended the quarter with $85 million in cash on hand compared to a cash balance of $42 million a year ago. Our ending inventory balance was $81 million, up from $70 million in June, as expected. We remain confident in our ability to meet the strong consumer demand we're seeing. I'm also pleased with the strong free cash flow generation we've seen year-to-date of approximately $42 million. Given our cash position, we ended the quarter with less than one times leverage on a net debt basis. We expect our cash priorities for the year to remain on investing behind our growth initiatives and supporting strategic extensions. In this rising interest rate environment, we are also exploring retiring a portion of our debt given our strong cash flow. Now let's turn to our raised outlook for fiscal 2023. For the full year, we now expect net sales growth of approximately 22% to 24% and versus prior year, up from 14% to 16% previously. We expect adjusted EBITDA between $93.5 million to $95 million, up from $83.5 million to $85 million previously. We expect adjusted net income between $59 million to $60.5 million, up from $47 million to $48.5 million previously. And adjusted EPS of $1.07 to $1.10 per diluted share, up from $0.84 to $0.87 previously. We expect our fiscal 2023 adjusted tax rate to be approximately 22% to 23% as compared to 25% to 26% previously. Lastly, we expect a fully diluted share count of approximately 56 million shares at year-end. Let me provide you with additional color on our planning assumptions for fiscal 2023. Starting with the top line. Our raised outlook reflects our outperformance in Q2 relative to our expectations, pipeline related to the incremental space gains Tarang spoke about with Walmart, Target and Shoppers Drug Mart as well as our ongoing business momentum. Turning to gross margin. We now expect our gross margin to be up approximately 175 basis points year-over-year as compared to our previous expectation for up 100 basis points. This is largely a result of our outperformance in Q2 and an improved outlook on transportation costs. In terms of the key drivers for the year, we expect the combination of price increases, margin accretive mix and cost savings to support our gross margin improvement. Now turning to adjusted EBITDA. Our outlook implies adjusted EBITDA growth of approximately 25% to 27% versus prior year, up from approximately 12% to 14% previously and on top of the strong 22% growth in fiscal 2022. This embeds our marketing and digital spend expectations at the top end of our 17% to 19% range. Even with that increased investment, our outlook now implies adjusted EBITDA margin leverage of approximately 50 basis points year-over-year. The improved outlook is supported by the combination of our strong sales growth, gross margin expansion and leverage in our non-marketing SG&A expenses. Overall, we are quite pleased to be in a position to meaningfully raise both our sales and profitability outlook and what continues to be a dynamic environment. In summary, we're pleased with our outstanding Q2 results and remain upbeat on our long-term growth potential, significant whitespace remains across cosmetics and skin care, both domestically and internationally to support our expected top line growth. We also continue to expect to deliver leverage in our adjusted EBITDA margin. Finally, we believe our solid balance sheet low leverage and strong cash flow generation can continue to drive shareholder returns and support our overall growth. With that, operator, you may open the call to questions.